Fri, February 26, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Mike Matson Maintained (AXNX) at Strong Buy with Increased Target to $66 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Richard Davis Maintained (BAND) at Strong Buy with Increased Target to $227 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Brian Skorney Downgraded (VYGR) to Hold and Decreased Target to $6 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Simeon Gutman Upgraded (W) to Hold and Held Target at $270 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Stephen Ju Maintained (W) at Buy with Increased Target to $326 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Scott Berg Maintained (WDAY) at Strong Buy with Increased Target to $290 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Sami Badri Maintained (AMT) at Buy with Decreased Target to $296 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Ric Prentiss Maintained (AMT) at Buy with Decreased Target to $244 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Matthew Hedberg Maintained (ANSS) at Hold with Decreased Target to $380 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
John Walsh Maintained (ANSS) at Buy with Decreased Target to $392 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
John Quealy Maintained (TPIC) at Strong Buy with Increased Target to $70 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Manav Gupta Maintained (XOM) at Hold with Increased Target to $64 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Linda Bolton Weiser Maintained (WW) at Strong Buy with Decreased Target to $33 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Lawrence Keusch Maintained (TFX) at Strong Buy with Increased Target to $460 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Jailendra Singh Maintained (TDOC) at Buy with Increased Target to $300 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Katy Huberty Maintained (TDC) at Hold with Increased Target to $44 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Robert Dodd Upgraded (TCPC) to Buy and Held Target at $14 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Tiago Fauth Maintained (APLS) at Hold with Increased Target to $37 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Etzer Darout Initiated (AKRO) at Strong Buy and Held Target at $54 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
John Heagerty Upgraded (AIG) to Buy and Held Target at $55 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Andrew Berens Downgraded (AGIO) to Hold and Decreased Target to $50 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Rick Schafer Maintained (AVGO) at Buy with Increased Target to $58 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
James Thalacker Maintained (AEP) at Buy with Decreased Target to $87 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
David Hynes Maintained (ADSK) at Strong Buy with Increased Target to $315 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Tejas Savant Maintained (ADPT) at Hold with Increased Target to $60 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
David Koning Downgraded (WNS) to Hold and Held Target at $82 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Michael Petusky Downgraded (USPH) to Hold on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Hamed Khorsand Maintained (VICR) at Strong Buy with Increased Target to $120 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Quinn Bolton Maintained (VICR) at Strong Buy with Increased Target to $110 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Paul Quinn Downgraded (CLW) to Hold and Decreased Target to $45 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Swayampakula Ramakanth Maintained (CDXS) at Stron .. y with Increased Target to $26 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Michael Weinstein Maintained (CNP) at Buy with Decreased Target to $25 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Connor Lynagh Maintained (TS) at Buy with Increased Target to $23 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Adam Samuelson Maintained (BYND) at Strong Sell with Increased Target to $112 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Bobby Burleson Maintained (BYND) at Hold with Decreased Target to $155 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Melissa Wedel Downgraded (SLRC) to Hold and Held Target at $19 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Katy Huberty Maintained (STX) at Buy with Increased Target to $86 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Stephen Laws Maintained (STWD) at Buy with Increased Target to $26 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
David Risinger Maintained (BHC) at Hold with Increased Target to $35 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Scot Ciccarelli Maintained (BBY) at Hold with Decreased Target to $114 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Simeon Gutman Maintained (BBY) at Hold with Decreased Target to $110 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Bobby Griffin Downgraded (BBY) to Buy and Decreased Target to $120 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Steven Wald Downgraded (VRRM) to Hold and Held Target at $14 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
James Lee Maintained (ABNB) at Hold with Increased Target to $176 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Michael Graham Maintained (ABNB) at Strong Buy with Increased Target to $220 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Thomas Champion Maintained (ABNB) at Buy with Increased Target to $198 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Tom White Maintained (ABNB) at Strong Buy with Increased Target to $210 on, Feb 26th, 2021
[ Fri, Feb 26th 2021 ]: WOPRAI
Stephen Ju Maintained (ABNB) at Hold with Increased Target to $162 on, Feb 26th, 2021

Andrew Berens Downgraded (AGIO) to Hold and Decreased Target to $50 on, Feb 26th, 2021

Andrew Berens of SVB Leerink, Downgraded "Agios Pharmaceuticals, Inc." (AGIO) to Hold and Decreased Target from $55 to $50 on, Feb 26th, 2021.

Andrew has made no other calls on AGIO in the last 4 months.



There is 1 other peer that has a rating on AGIO. Out of the 1 peers that are also analyzing AGIO, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew

  • John Newman of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $57 on, Monday, December 28th, 2020